Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2006

View Archived Issues

Protherics to acquire CoVaccine's novel adjuvant for angiotensin vaccine

Development & manufacturing agreement for A&G anti-GP88 cancer therapeutic antibody

MorphoSys and OncoMed sign HuCAL agreement for cancer research

NOMAC/E2 combined oral contraceptive enters phase III

SPARC study of satraplatin cleared to continue to completion

HuMax-CD38 blocks ectoenzymatic activity of CD38 in preclinical studies

Criterion reached for interim efficacy statistical analysis of PRECISE study

ProLindac studied in phase II trial for ovarian cancer

AstraZeneca updates status of development portfolio

Phase II data on GVAX cancer immunotherapy in CML reported

Phase I data on BIBF-1120 for advanced solid tumors

DN-101 shows activity in NSCLC study

Pharming's acquisition of DNage delayed by appeal

MORAb-003 begins phase II studies

MRX-5 improves IBD symptoms in preclinical studies

Neumune cleared for clinical study in patients at risk of nosocomial infections

Medicine status for Mologen's cell-based gene therapy for kidney cancer

Orphan drug designation for ropidoxuridine in malignant glioma

U.K.'s NICE recommends use of Herceptin

BioDelivery Sciences discusses Emezine path forward with FDA

Novel therapeutic agents for respiratory disorders disclosed in recent patents

Novel agents for urological disorders disclosed in recent patent literature

Recent patents report novel analgesic agents

Encouraging early clinical data reported on SGN-40 in Atlanta

Elacyt safety improved on new administration schedule tested in patients with solid tumors

Initial results of phase I trial of Patrin and dacarbazine in patients with solid tumors

MDX-214, a novel immunotherapeutic strategy for EGFR+ tumors

Axitinib demonstrates promising activity in pancreatic and thyroid cancer

DPP-IV inhibitor developed at Point Therapeutics shows antidiabetic potential in preclinical studies

New vitamin D receptor modulators show efficacy in a preclinical model of psoriasis

Folate-mitomycin conjugates suppress tumor growth in combination with paclitaxel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...